Company / Operating Income per Share
Adaptive Biotechnologies Corp Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.39
FY2025
5-year range
-$1.59 / -$0.39
FY2021-FY2025
Trend
+65.5%
vs FY2024
Sector context
#70 of 201
Health Care
What the data says
At $-0.39, Adaptive Biotechnologies Corp's operating income per share ranks #70 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 9 years, ranging from $-6.10 in FY2019 to $-0.39 in FY2025.
Based on SEC 10-K filings.
-0.39 in FY2025.
Improved from $-1.59 to $-0.39 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 201 in Health CareTop 35% of 201This company -$0.39 Sector average -$3.23
▼
+88.0% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 65.5% year-over-year.
- Ranks #70 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.39 | +65.5% |
| FY2024 | -$1.12 | +29.4% |
| FY2023 | -$1.59 | -12.1% |
| FY2022 | -$1.42 | +6.7% |
| FY2021 | -$1.52 | -24.4% |
| FY2020 | -$1.22 | +80.0% |
| FY2019 | -$6.10 | -55.0% |
| FY2018 | -$3.94 | -8.0% |
| FY2017 | -$3.65 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026